Capital Asset Advisory Services LLC Astrazeneca PLC Transaction History
Capital Asset Advisory Services LLC
- $2.01 Billion
- Q3 2024
A detailed history of Capital Asset Advisory Services LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 6,376 shares of AZN stock, worth $404,174. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,376
Previous 6,701
4.85%
Holding current value
$404,174
Previous $522,000
4.98%
% of portfolio
0.02%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$3.99 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.66 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.36 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.33 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.22 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $196B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...